ACE Gene Mutations (rs577350502) in Early-Onset and Recurrent Myocardial Infarction: A Case Report and Review
DOI: https://doi.org/10.2147/pgpm.s455740
2024-04-21
Pharmacogenomics and Personalized Medicine
Abstract:Xiaoxi Deng, 1, &ast Xiaofei Guo, 1, &ast Xiaojie Chen, 2 Xinyu Zeng, 1 Jiamin Guo, 1 Xin Bai, 1 Ping Zhang, 1 Yuan Wang 1 1 Department of Pathology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, People's Republic of China; 2 Department of Emergency, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yuan Wang, Ping Zhang, Department of Pathology, Wangjing Hospital, China Academy of Chinese Medical Sciences, 6 Wangjing Zhonghuan South Road, Chaoyang District, Beijing, 100102, People's Republic of China, Tel +86 010-84739040, Email ; Background: Acute myocardial infarction (AMI) is a severe acute coronary syndrome, demonstrating a trend toward affecting younger individuals in recent years. The association between early-onset myocardial infarction and single nucleotide polymorphism necessitates further exploration and evaluation. Case description: We present a case of a patient experiencing early-onset and recurrent myocardial infarction. The patient underwent stent implantation for myocardial infarction at the age of 53 and subsequently encountered two more myocardial infarctions within a span of 16 years. Following interventional therapy, genetic testing was conducted to assess the efficacy of subsequent anti-heart failure medications, with the aim to preemptively address heart failure risks. Genetic testing revealed a mutation in the angiotensin-converting enzyme (ACE) gene (rs577350502, g.63488533C>A), characterized by an intron-deletion single nucleotide variant. Conclusion: While this variant has not been previously reported to be associated with any specific disease, we hypothesize that it may contribute to the susceptibility and risk of myocardial infarction and coronary heart disease in the patient under consideration. This observation underscores the significance of investigating the insertion/deletion polymorphisms of the ACE gene in the context of AMI and emphasizes the necessity for further validation of this variant and other genetic markers associated with AMI in related diseases. Keywords: ACE, case reports, gene mutations, myocardial infarction, SNV Acute myocardial infarction (AMI) is a serious complication of coronary heart disease (CHD) primarily arising from severe stenosis or occlusion of coronary arteries, resulting in ischemic necrosis of the corresponding myocardial supply region. It represents a critical pathophysiological consequence within the spectrum of CHD. However, not all patients with CHD experience an AMI, and there might be some certain gene polymorphisms that contribute to the progression of coronary artery disease (CAD) into AMI. 1 Consequently, single nucleotide polymorphisms (SNPs) linked to AMI episodes warrant careful consideration. Early-onset AMI is defined by its occurrence in males under the age of 55 and females under the age of 60. 2 In this report, we present a case of a patient with early-onset and recurrent myocardial infarction, experiencing the initial episode at 53 years of age and subsequently enduring two more attacks over the next 16 years. Blood leukocyte DNA testing was conducted utilizing polymerase chain reaction (PCR) and Sanger sequencing, adhering to the ethical principles outlined in the Declaration of Helsinki. A 69-year-old male was transported to our hospital by ambulance following a heart attack, presenting with symptoms such as chest tightness, breathlessness, and vomiting of stomach contents. An emergency electrocardiogram (ECG) conducted en route revealed sinus rhythm with ST elevation in leads II, III, and AVF. Subsequent coronary angiography revealed coronary atherosclerotic heart disease, manifesting as double-vessel disease affecting the anterior descending artery and the right coronary artery (see Figure 1). The patient's blood test is shown in detail in Table 1. As per established diagnostic criteria, 3 the patient was diagnosed with acute inferior myocardial infarction. Emergency intervention was conducted, involving stent implantation for the right posterior descending coronary artery and the right posterior lateral coronary artery. Table 1 Blood Test Indexes of the Patient Figure 1 Coronary angiography. Remarkably, the patient's medical history revealed that this marked the third occurrence of such a procedure. The initial diagnosis of coronary atherosclerotic heart disease was made 16 years ago, leading to coronary stent implantation for myocardial infarction at the ages of 53 and 58, resulting in a total o -Abstract Truncated-
pharmacology & pharmacy